Stay updated on DAPA-MI Trial: Dapagliflozin Post Heart Attack
Sign up to get notified when there's something new on the DAPA-MI Trial: Dapagliflozin Post Heart Attack page.

Latest updates to the DAPA-MI Trial: Dapagliflozin Post Heart Attack page
- CheckyesterdayChange DetectedThe page now displays Revision: v3.5.5, replacing v3.5.4 and reflecting a new site version.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe Record History now shows a new revision, v3.5.4, replacing the previous v3.5.3. This reflects an update to the study record's history metadata.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page now shows Revision: `v3.5.3` in the Record History, replacing the previous `v3.5.2`. This is a backend/site deployment update and does not alter study data or visible content.SummaryDifference0.1%

- Check51 days agoChange DetectedA new revision entry v3.5.2 was added and v3.5.0 was removed from the record history.SummaryDifference0.1%

- Check58 days agoChange DetectedThe history shows frequent revisions to study status, contacts/locations, and key study sections across multiple versions. This reflects ongoing maintenance of the trial record and updates to how and where the trial is described.SummaryDifference0.1%

- Check72 days agoChange Detected- Revision v3.5.0 was added and revision v3.4.3 was removed from the history. This is a metadata/version update and does not alter the study data or eligibility information.SummaryDifference0.1%

Stay in the know with updates to DAPA-MI Trial: Dapagliflozin Post Heart Attack
Enter your email address, and we'll notify you when there's something new on the DAPA-MI Trial: Dapagliflozin Post Heart Attack page.